Literature DB >> 10616851

Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?

Andrew G Bostom1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10616851     DOI： 10.1681/ASN.V111149

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  4 in total

1.  The homocysteine paradox.

Authors:  Roman N Rodionov; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06       Impact factor: 8.311

2.  Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.

Authors:  Richard D Semba; Luigi Ferrucci; Jeffrey C Fink; Kai Sun; Justine Beck; Mansi Dalal; Jack M Guralnik; Linda P Fried
Journal:  Am J Kidney Dis       Date:  2008-09-11       Impact factor: 8.860

Review 3.  [Current problems of kidney transplantation].

Authors:  H Haller; N Richter; V Bröcker; W Gwinner; F Gueler; A Schwarz
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

4.  Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.

Authors:  Richard D Semba; Jeffrey C Fink; Kai Sun; B Gwen Windham; Luigi Ferrucci
Journal:  J Ren Nutr       Date:  2009-10-22       Impact factor: 3.655
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.